Remove Biochemical Assays Remove Computational Chemistry Remove Treatment
article thumbnail

High Throughput Screening (HTS)

Sygnature Discovery

Collaboration with customers and Sygnatures computational chemists ensures quality hit identification using computational chemistry triage, counter screens, and orthogonal assays. Central to our automation is the Echo acoustic dispensing technology, ensuring highly accurate compound delivery.

article thumbnail

Target-directed cancer: protein-ligand interactions  

Drug Target Review

The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. For example, in the screening stage of a project we are trying to find initial starting points for optimisation by our medicinal and computational chemistry colleagues.